NEW YORK (GenomeWeb News) — Pressure Biosciences has received a $149,470 Phase I Small Business Innovation Research Grant from the National Institutes of Health. The grant is for six months.
 
The company will use it to fund experiments demonstrating the feasibility of using its Pressure Cycling Technology to develop a method for extracting clinically important protein biomarkers, sub-cellular molecular complexes, and organelles from cells and tissues, Pressure Biosciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.